Monitoring and Treatment of Inactive Chronic Hepatitis B: Is It Cost-Effective?

被引:0
|
作者
Younossi, Zobair [1 ,2 ]
Henry, Linda [2 ]
机构
[1] Inova Fairfax Hosp, Dept Med, Falls Church, VA USA
[2] Inova Hlth Syst, Betty & Guy Beatty Ctr Integrated Res, Falls Church, VA USA
关键词
QUALITY-OF-LIFE; VIRUS-INFECTION; CHINA; EPIDEMIOLOGY;
D O I
10.1002/hep.27062
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
[No abstract available]
引用
收藏
页码:19 / 21
页数:3
相关论文
共 50 条
  • [41] Cost-effective pharmacologic therapies to treat chronic hepatitis B: How far have we really come?
    Holbrook, Michelle L.
    Culley, Eric J.
    JOURNAL OF MANAGED CARE PHARMACY, 2008, 14 (01): : 65 - 69
  • [42] COST-EFFECTIVE TREATMENT OF HYPERLIPEMIA
    WHITE, DH
    CLINTON, PKS
    SOUTH AFRICAN MEDICAL JOURNAL, 1989, 75 (12): : 596 - 596
  • [43] COST-EFFECTIVE TREATMENT OF HYPERLIPEMIA
    BERGER, GMB
    SOUTH AFRICAN MEDICAL JOURNAL, 1989, 76 (07): : 386 - 387
  • [45] Long-term treatment with adefovir dipivoxil is more cost-effective than lamivudine for HBeAg-negative patients with chronic hepatitis B
    Buti, M
    Casado, MA
    Calleja, JL
    Salmerón, J
    Aguilar, J
    Rueda, M
    Esteban, R
    HEPATOLOGY, 2005, 42 (04) : 354A - 354A
  • [46] Safe and cost-effective control of post-transplantation recurrence of hepatitis B
    Takaki, Akinobu
    Yagi, Takahito
    Yamamoto, Kazuhide
    HEPATOLOGY RESEARCH, 2015, 45 (01) : 38 - 47
  • [47] Cost-effective evaluation of acute viral hepatitis
    Ahmed, A
    Keeffe, EB
    WESTERN JOURNAL OF MEDICINE, 2000, 172 (01): : 29 - 32
  • [48] Cost-effective analysis of hepatitis A prevention in Ireland
    Rajan, E
    Shattock, AG
    Fielding, JF
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2000, 95 (01): : 223 - 226
  • [49] Is prevaccination screening for hepatitis B among sexually active adolescents cost-effective?
    Alderman, EM
    Shapiro, A
    Spigland, I
    Bashir, M
    Fox, AS
    CLINICAL INFECTIOUS DISEASES, 1998, 26 (06) : 1459 - 1460
  • [50] Vaccination of blood donors against hepatitis B is feasible, safe and cost-effective
    Gaertner, Barbara C.
    FUTURE VIROLOGY, 2011, 6 (10) : 1139 - 1141